Co-Located Conference AgendasAntibody Drug Conjugates | Biomarkers - From Research To Commercialization |
Thursday, 24 May 201808:00 | Registration | | Inauguration |
| | 09:00 | Welcome Address | 09:05 | Speakers' Introduction & Memento Presentation | 09:25 | Card Exchange and Networking Session | 09:40 | Coffee Break and Networking in Exhibition Area | | Scientific Session I - Antibody Engineering |
| | 10:10 | Yesterday, Today and Tomorrow of Antibody Manjula Das, Principal Investigator, Mazumdar Shaw Center for Translational Research (MSCTR), India
| 10:45 | Q/A Discussion | 10:50 | | 11:30 | Q/A Discussion | 11:35 | Antibody Engineering in Biotherapeutic Development Ashvini Kumar Dubey, Senior Scientist, Zumutor Biologics, India
| 12:10 | Q/A Discussion | 12:15 | AbTids - A New Class of Antimicrobials Sanjiban K Banerjee, Director, AbGenics Lifesciences Pvt Ltd, India
| 12:50 | Q/A Discussion | 12:55 | Antibody Engineering Approach for High Quality Clone & Process Development Shailja Dwivedi, Sr. Research Executive- Advanced Biotech Lab, Ipca Laboratories Ltd, India
| 13:30 | Q/A Discussion | 13:35 | Group Photograph Session | 13:45 | Lunch Break and Networking in Exhibition Area | | Scientific Session II - ADC Development |
| | 14:45 | Development of Site-Specific Steroid-ADC for the Treatment of Inflammatory Diseases Amy Han, Director, Chemistry, Regeneron Pharmaceuticals, United States of America
| 15:20 | Q/A Discussion | 15:25 | Next Generation Antibody Drug Conjugates (ADCs): Firing Magical Bullets Continues Syeda Warisul Fatima, Research Scholar, Indian Institute of Technology Delhi, India
| 15:35 | Q/A Discussion | 15:40 | Coffee Break and Networking in Exhibition Area | 16:10 | | 16:50 | Q/A Discussion | 16:55 | Conference Feedback | 17:00 | End of First Day of Conference |
Friday, 25 May 2018 | Technical Session |
| | 09:01 | Introduction to Technical Session | 09:10 | Developing Validated Assays for Biomarkers and Antibody Drug Conjugates Kalpesh Jain, Founder and Technical Head, KRISHGEN Biosystems
| 09:35 | Q/A Discussion | 09:40 | Technology Spotlight: Glimpses of Solutions and Portfolio for Advanced Applications Ashish Pargaonkar, Field Applications Specialist - Biopharma, Agilent Technologies India Pvt Ltd.
| 09:55 | Technology Spotlight: iQue® Plus - Unique Among Flow-Cytometers Suyog Jakhadi, Product Manager- Bio-Analytics & Liquid Handling Products, Sartorius
| 10:10 | Technology Spotlight: Antibody Engineering reducing Antibody Dilemma in Biomarkers Study Rashmi Upadhyay, Head- Sales & Marketing, GeNext Genomics Pvt Ltd
| 10:25 | Coffee Break and Networking in Exhibition Area | | Scientific Session III - ADC Analysis |
| | 10:55 | Steps in Designing an ADC Priyaranjan Pattanaik, Associate Research Director, Syngene International Ltd
| 11:30 | Q/A Discussion | 11:35 | A Streamlined Drug-to-Antibody Ratio Determination Workflow for Intact and Deglycosylated Antibody-Drug Conjugates Ashish Pargaonkar, Field Applications Specialist - Biopharma, Agilent Technologies India Pvt Ltd., India
| 12:10 | Q/A Discussion | 12:15 | Interactive Session This is going to be a special designed interactive session wherein, the delegates will get an excellent opportunity to interact with the renowned experts/speakers in an informal open discussion giving them a chance to put up queries and get solutions. | 12:55 | Lunch Break and Networking in Exhibition Area | | Scientific Session IV - Overcoming Challenges in Development of Successful ADCs |
| | 13:55 | | Keynote Presentation Antibody-Drug Conjugates: Challenges in Translating Preclinical Success into Clinical Reality in Cancer Therapy Immunotherapy Nitin Damle, Senior Vice President and Head, Discovery Biology/ CSO, Sun Pharma Advanced Research Company Limited, India
|
| 14:35 | Q/A Discussion | 14:40 | The Curious Case of T-DM1 – First Antibody Drug Conjugate for HER2 Positive Breast Cancer Jagdish Nigade, Group Medical Manager, Roche, India
| 15:15 | Q/A Discussion | 15:20 | Coffee Break and Networking in Exhibition Area | 15:50 | | 16:30 | Q/A Discussion | 16:35 | Conference Feedback | 16:40 | Closing Remarks and Vote of Thanks | 16:45 | End of Conference |
|